Summary of Change

Form 8947: Report of Branded Prescription Drug Information
IRS - OMB REVIEW REQUEST FORM
Request for OMB review of currently approved document:
Date:

07/07/2011

Name: Mike

Cyrus

Office Symbols: SE:W:CAR:MP:T:I:R
Phone Number:

202-927-9545

Summary of Changes
Requested by LB&I the special team assembled to implement section 908 of ACA:
To allow that subsequent year filers would not have to repeat sending in the entire drug data listed on their initial year
filing of Form 8947 (for some filers, hundreds of pages), the form is expanded from 6 pages to 8 pages. Part I is
renamed Schedule A. Schedules B, C, and D are added. The Continuation Sheet for Part II is deleted. The instructions
are revised to conform to soon-to-be-published Temporary Regulations sections 51.1T through 51.13T, and section
51.6302-1T. These regulations obsolete Notices 2011-9 and 2011-46, and Rev. Proc. 2011-24.

Impact on Approved Collection
Public
Law No.

Regulation
No.

Other
Code
References

SAMPLE:
PL 109-567

REG-345675-08

RP 2009-134

+/- 5

Change In IRS Form
& Instructions
No. of Filers
Words

+/- 20,000

+/- 500

Attachments

+/- 1

400

ACA s.9008

*Please insert how this new (PL, REG, or other), document will affect the currently approved collection.
as modified by s. 1404 of HCERA

51.1T through 51.13T, and section
51.6302-1T (unpublished)

IRS - OMB REVIEW REQUEST FORM
(Continued)

Request for OMB review of currently approved document:
Date:

Name:

07/07/2011

Mike Cyrus

Office Symbols: SE:W:CAR:MP:T:I:R
Phone Number:

202-927-9545

Additional Information:
Page 5
Schedule D is added to account for changes in previously reported NDCs.
Page 6
Parts III and IV are renamed Parts II and III, respectively.
Page 7 (instructions)
1] A What’s New area is added to indicate the expansion of the form and that Medicare Part D rebate information is no
longer requested because it is now obtained directly from Medicare. All references to Medicare Part D rebates are
removed from the instructions
2] Under Who Should File, instructions for new Schedules A, B, C, and D is added.
3] The definitions of section 45C orphan drugs, non-orphan drug marketing, and a covered entity are revised to
conform to the new Temporary Regulations.
Page 8
1] The definition (and responsibility) of a designated entity and information about the Medicaid state supplemental
rebate amount is revised to conform to the new Temporary Regulations.
2] The Box 2b instructions are revised to be more specific re members of a group.

2